Figure 1.
Flowchart of patient disposition.
AACR, American Association for Cancer Research; ASCO, American Society of Clinical Oncology; ELCC, European Lung Cancer Congress; ESMO, European Society of Medical Oncology; WCLC, World Conference on Lung Cancer.
aReasons for exclusion: 38 review/meta-analysis, 36 non-randomized trials, 8 no epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) treatment, 7 no survival results, 7 no results by smoking, 4 subgroup analysis, 4 study design paper, 3 no angiogenesis inhibitor treatment, 2 clinical practice guidelines, 2 reply letter, 2 no comparison with EGFR TKI, 2 pooled analysis, 2 updated results, 1 case study, 1 highlights, 1 study on mice.